NCT03434977View on ClinicalTrials.gov

A Phase 1 Food Effect Study of Azilsartan (TAK-536) Pediatric Formulation

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 14, 2018

Primary Completion Date

March 11, 2018

Study Completion Date

March 11, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

TAK-536

TAK-536 granule formulation

Trial Locations (1)

Unknown

Fukuoka Mirai Hospital, Fukuoka

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT03434977 - A Phase 1 Food Effect Study of Azilsartan (TAK-536) Pediatric Formulation | Biotech Hunter | Biotech Hunter